NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Nothing has been delayed. There's no approval timeline benchmark against which to compare this personalized autologous cell-based therapy. So when you say X number of GBM patients died, while management are delayed, that isn't factual in any respect. They're not late, delayed, or dealing with some fatal issue that precludes approval.

You have no idea what's going on behind the scenes. From SEC filings and PRs we know that they're working on approval. If negative feedback was given by MHRA, FDA, et al, that would be a mandatory disclosure. In reality the opposite occurred at every step. The notion that management are responsible for the deaths of GBM patients to me seems like absolute lunacy as without their efforts this life-saving treatment wouldn't be, in my opinion, months away from approval.